Without prejudice to Directive 2002/46/EC, L-ergothioneine as specified in Annex I may be placed on the Union market as a novel food ingredient to be used in food supplements intended for the general population, excluding infants and young children, and pregnant and lactating women, for the uses defined and at the maximum levels established in Annex II.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Commission Implementing Decision (EU) 2017/1281 of 13 July 2017 authorising the placing on the market of L-ergothioneine as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4844)
The designation of L-ergothioneine authorised by this Decision on the labelling of the foodstuffs shall be ‘L-ergothioneine’.
This Decision is addressed to Tetrahedron, 14, avenue de l'Opéra, 75001 Paris, France.
Schedules & Appendices
ANNEX I
SPECIFICATIONS OF L-ERGOTHIONEINE
Definition
Chemical name (IUPAC)
(2S)-3-(2-thioxo-2,3-dihydro-1 H -imidazol-4-yl)-2-(trimethylammonio)-propanoate
Chemical formula
C 9 H 15 N 3 O 2 S
Molecular mass
229,3 Da
CAS No
497-30-3
IUPAC: International Union for Pure and Applied Chemistry
Specifications
Parameter
Specification
Method
Appearance
White powder
Visual
Optical rotation
[α] D ≥ (+) 122° (c = 1, H 2 0) ( 1 )
Polarimetry
Chemical purity
≥ 99,5 %
HPLC [Eur. Ph. 2.2.29]
≥ 99 %
1H-NMR
Identification
Compliant with the structure
1H-NMR
C: 47,14 ± 0,4 %
H: 6,59 ± 0,4 %
N: 18,32 ± 0,4 %
Elemental analysis
Total residual solvents
(methanol, ethyl acetate, isopropanol, ethanol)
[Eur. Ph. 01/2008:50400]
< 1 000 ppm
Gas chromatography
[Eur. Ph. 01/2008:20424]
Loss on drying
Internal standard < 0,5 %
[Eur. Ph. 01/2008:20232]
Impurities
< 0,8 %
HPLC/GPC or 1H-NMR
Heavy metals
( 2 )
( 3 )
Lead
< 3 ppm
ICP/AES
(Pb, Cd)
Atomic fluorescence (Hg)
Cadmium
< 1 ppm
Mercury
< 0,1 ppm
Microbiological specifications
( 2 )
Total viable aerobic count (TVAC)
≤ 1 × 10 3 CFU/g
[Eur. Ph. 01/2011:50104]
Total yeast and mould count (TYMC)
≤ 1 × 10 2 CFU/g
Escherichia coli
Absent in 1 g
Eur. Ph.: European Pharmacopoeia; 1H-NMR: proton nuclear magnetic resonance; HPLC: high-performance liquid chromatography; GPC: gel permeation chromatography; ICP/AES: Inductively coupled plasma atomic emission spectroscopy;
CFU: colony-forming units.
( 1 ) Lit. [α] D = (+) 126,6° (c = 1, H 2 0)
( 2 ) Analyses conducted on each batch
( 3 ) Maximum levels in accordance with Commission Regulation (EC) No 1881/2006 ( OJ L 364, 20.12.2006, p. 5 ).
ANNEX II
AUTHORISED USES OF L-ERGOTHIONEINE
Food category
Maximum levels
Food supplements as defined in Directive 2002/46/EC
30 mg/day for general population (excluding pregnant and lactating women)
20 mg/day for children older than 3 years
Cite this act
Commission Implementing Decision (EU) 2017/1281 of 13 July 2017 authorising the placing on the market of L-ergothioneine as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4844) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32017D1281
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com